南模生物涨5.07% 技术壁垒与盈利修复预期驱动

智选洞察2025-07-16

南模生物股价大幅上涨，最新价36.06元/股，涨幅达5.07%。市场博弈与资金轮动共振南模生物近期股价波动受多因素交织影响。截至7月14日，沪深300指数近5日主力净流入超60亿元，资金向大盘股聚集导致中小盘股流动性承压，同期医疗服务板块单日下跌1.18%，机构调仓加剧板块内部分化。技术面显示，该股6月末突破30元后触发获利盘兑现，叠加限售股解禁压力，短期抛压集中释放。7月7日至11日主力资金单日...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551119871?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-16 10:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551119871","market":"sh","top_or_hot":-1,"title":"南模生物涨5.07% 技术壁垒与盈利修复预期驱动","media":"智选洞察","content":"<div>\n<p>南模生物股价大幅上涨，最新价36.06元/股，涨幅达5.07%。市场博弈与资金轮动共振南模生物近期股价波动受多因素交织影响。截至7月14日，沪深300指数近5日主力净流入超60亿元，资金向大盘股聚集导致中小盘股流动性承压，同期医疗服务板块单日下跌1.18%，机构调仓加剧板块内部分化。技术面显示，该股6月末突破30元后触发获利盘兑现，叠加限售股解禁压力，短期抛压集中释放。7月7日至11日主力资金单日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716103446a44d96ac&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>南模生物涨5.07% 技术壁垒与盈利修复预期驱动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n南模生物涨5.07% 技术壁垒与盈利修复预期驱动\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-16 10:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716103446a44d96ac&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>南模生物股价大幅上涨，最新价36.06元/股，涨幅达5.07%。市场博弈与资金轮动共振南模生物近期股价波动受多因素交织影响。截至7月14日，沪深300指数近5日主力净流入超60亿元，资金向大盘股聚集导致中小盘股流动性承压，同期医疗服务板块单日下跌1.18%，机构调仓加剧板块内部分化。技术面显示，该股6月末突破30元后触发获利盘兑现，叠加限售股解禁压力，短期抛压集中释放。7月7日至11日主力资金单日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716103446a44d96ac&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688265","symbol_name":"南模生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716103446a44d96ac&s=b","article_id":"2551119871","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716103446a44d96ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551119871","pubTimestamp":1752633281,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"南模生物股价大幅上涨，最新价36.06元/股，涨幅达5.07%。技术壁垒与盈利修复双轮驱动南模生物长期竞争力依托基因编辑技术优势，2024年境外收入同比增长31.88%，工业客户客单价提升至11.52万元。2025年一季度归母净利润亏损同比收窄92.5%，若三季度实现单季盈利，动态市盈率有望从当前152.58倍逐步修复。当前股价接近32.68元技术压力位，截至7月16日市盈率显著高于行业均值，后市需观察业绩兑现节奏与市场风险偏好变化，若盈利拐点确认或打开估值修复空间。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688265":"南模生物","BK0216":"研究试验"},"translate_title":"Nanmo Biotech rose 5.07%, driven by technical barriers and profit recovery expectations","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688265":1},"content_text":"南模生物股价大幅上涨，最新价36.06元/股，涨幅达5.07%。市场博弈与资金轮动共振南模生物近期股价波动受多因素交织影响。截至7月14日，沪深300指数近5日主力净流入超60亿元，资金向大盘股聚集导致中小盘股流动性承压，同期医疗服务板块单日下跌1.18%，机构调仓加剧板块内部分化。技术面显示，该股6月末突破30元后触发获利盘兑现，叠加限售股解禁压力，短期抛压集中释放。7月7日至11日主力资金单日流向在净流入332万元至净流出615万元间反复切换，市场分歧显著，7月16日早盘股价一度冲高至36.06元，振幅达5.10%。技术壁垒与盈利修复双轮驱动南模生物长期竞争力依托基因编辑技术优势，2024年境外收入同比增长31.88%，工业客户客单价提升至11.52万元。2025年一季度归母净利润亏损同比收窄92.5%，若三季度实现单季盈利，动态市盈率有望从当前152.58倍逐步修复。机构持仓显示，招商量化精选、交银医药创新等基金二季度新进十大流通股东，但需警惕研发投入持续性及CRO行业竞争风险。当前股价接近32.68元技术压力位，截至7月16日市盈率显著高于行业均值，后市需观察业绩兑现节奏与市场风险偏好变化，若盈利拐点确认或打开估值修复空间。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551119871","isCrawlerRequest":true}